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Abstract
Background: Canine obesity is usually treated with dietary energy restriction, but data are limited regarding
nutritional adequacy. The aim of the current study was to compare intake of essential nutrients with National
Research Council recommendations in obese dogs during weight management with a purpose-formulated diet.
Methods: Twenty-seven dogs were included in this non-randomised retrospective observational cohort study. All
were determined to be systemically well, and without significant abnormalities based upon physical examination
and clinicopathological assessments. The dogs underwent a controlled weight loss protocol of at least 182 days’
duration using a high protein high fibre weight loss diet. Median, maximum, and minimum daily intakes of all
essential nutrients were compared against NRC 2006 recommended allowances (RA) for adult dogs.
Results: Median weight loss was 28 % (16–40 %), mean daily energy intake was 61 kcal/kg0.75 (44–74 kcal/kg0.75),
and no clinical signs of nutrient deficiency were observed in any dog. Based upon the average nutrient content
of the diet, daily intake of the majority of essential nutrients was greater than their NRC 2006 recommended
allowance (RA per kg body weight0.75), except for selenium, choline, methionine/cysteine, tryptophan,
magnesium, and potassium. However, apart from choline (2/27 dogs) and methionine/cysteine (2/27 dogs), all
essential nutrients remained above NRC minimum requirements (MR) throughout the trial.
Conclusions: When fed the diet used in the current study, daily intakes of most essential nutrients meet both
their NRC 2006 RA and MR in obese dogs during weight loss. In light of absence of clinical signs of nutrient
deficiency, it is unclear what significance intakes less that NRC cut-offs for some nutrients have (especially
selenium and choline), and further studies are recommended.
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Background
Obesity is a common problem in dogs [1], and is associ-
ated with numerous diseases [1–3], metabolic derange-
ments [4], alterations in renal function [5], respiratory
dysfunction [6, 7], decreased longevity [8], and decreased
quality of life [9]. Management involves controlled weight
loss by caloric restriction using a purpose-formulated
weight loss diet [10–14]. Such diets are designed to ensure
delivery of all essential nutrients appropriate to daily
requirements, despite sufficient energy restriction to pro-
mote weight loss. Such endeavours can be challenging in
light of the fact that the exact level of energy restriction
required can vary considerably, with some dogs requiring
marked caloric restriction [11, 12].
To ensure a diet is complete and balanced when fed
at maintenance requirements, it is recommended that
daily intake of all essential nutrients meet internation-
ally accepted recommendations, such as those reported
by National Research Council (NRC) [15], the Associ-
ation of American Feed Control Officials (AAFCO)
[16], and the European Pet Food Industry Federation
(FEDIAF) [17]. It is currently assumed that dogs under-
going weight management continue to have similar
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essential nutrient requirements to those required for
maintenance, although there is limited evidence to sup-
port this supposition. A recent study demonstrated
that plasma concentrations of most essential nutrients
do not change significantly during controlled weight
loss using a purpose-formulated diet [18]. Further-
more, no clinically-evident nutrient deficiencies have
previously been reported from a number of studies
that have assessed the weight management process
[10–14]. However, a recent theoretical study suggested
the theoretical possibility that intake of some nutrients
could be insufficient during the weight loss process,
depending upon the diet used and the degree of energy
restriction [19]. The main limitation of this study was
the fact that all estimates of nutrient intake were the-
oretical, rather than being determined from the food
intake of dogs actually undergoing weight manage-
ment. As a result, the aim of the current study was to
compare intake of essential nutrients with NRC rec-
ommendations in obese dogs during weight manage-
ment with a purpose-formulated diet.
Methods
Study design
This was a non-randomised retrospective observational
cohort study to assess intake of selected nutrients in a
cohort of dogs with naturally occurring obesity, and has
been reported according to the Strengthening and
Reporting of Observational Studies in Epidemiology
(STROBE) statement guidelines (Additional file 1) [20].
Animals
Participating dogs were recruited from referrals to the
Royal Canin Weight Management Clinic, University of
Liverpool UK, for management of obesity. The dogs
were recruited between September 2006 and August
2010, and had completed weight loss by February 2011.
To be eligible, all dogs had to be obese (based upon
body fat measurement by dual-energy X-ray absorpti-
ometry; DEXA) [11, 12], to have completed a weight
loss regime (i.e. reaching target weight) of at least
182 days’ duration (i.e. ~6 months duration), to have
been fed the same purpose-formulated weight loss diet
(Table 1; Royal Canin Satiety Canine Dry Diet, Royal
Canin, UK), to be euthyroid (based upon measurement
of serum free thyroxine concentration by equilibrium
dialysis), and to have had no significant systemic dis-
ease (e.g. endocrine disease, hepatic disease, renal dis-
ease, and gastrointestinal disease) during the study.
The study protocol adhered to the University of Liverpool
Animal Ethics Guidelines, and was approved by both the
University of Liverpool Research Ethics Committee and
the Royal Canin Ethical Review Committee. Owners of all
participating animals gave informed consent in writing.
Table 1 Average nutrient content of the diet used for weight
loss in the study dogs
Nutrienta Weight loss diet
Kcal/kg Metabolisable Energyb 2900 —
Per 100 g as fed Per 1000 kcal
Crude protein (g) 30 104.0
Arginine (g) 1.6 5.4
Histidine (g) 0.6 2.0
Isoleucine (g) 1.1 3.8
Met and Cys (g) 1.0 3.6
Leucine (g) 2.2 7.7
Lysine (g) 1.2 4.1
Phe and Tyr (g) 2.8 9.6
Threonine (g) 1.0 3.3
Tryptophan (g) 0.3 0.9
Taurine (g)c 0.2 0.7
Valine (g) 1.3 4.4
Total fat (g) 9.6 33.0
Linoleic acid (g) 2.1 7.3
Calcium (g) 0.9 3.1
Phosphorus (g) 0.7 2.4
Magnesium (g) 0.05 0.2
Sodium (g) 0.3 1.0
Potassium (g) 0.8 2.8
Chloride (g) 0.9 3.0
Iron (mg) 16.5 57.0
Copper (mg) 2.0 6.9
Zinc (mg) 20.0 69.0
Manganese (mg) 7.0 24.0
Selenium (mg) 0.02 0.1
Iodine (mg) 0.3 1.0
Vitamin A (IU) 2027 6990
Vitamin D3 (IU) 70 24
Vitamin E (IU) 80 276
Thiamine (mg) 2.6 9.0
Riboflavin (mg) 5.2 18.0
Pyridoxine (mg) 2.3 8.0
Niacin (mg) 16 56
Pantothenic acid (mg) 4.6 16.0
Cobalamin (mg) 0.02 0.06
Folic acid (mg) 0.4 1.5
Choline (mg) 249 860
aThe values reported are the average nutrient content as analysed
bMetabolisable energy content, as measured in animal trials according to the
AAFCO protocol [16]
cAlthough taurine is not an essential amino acid, it is supplemented within
the diet
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Weight loss regimen
Full details of the weight loss regimen have been previ-
ously described [11, 12]. Briefly, dogs were determined
to be systemically well, and without significant abnor-
malities based upon physical examination and clinico-
pathological assessments (as detailed above). A controlled
weight loss protocol was then initiated, using a high pro-
tein high fibre weight loss diet (Table 1). The initial food
allocation for weight loss was determined by first estimat-
ing maintenance energy requirement (MER = 440 kJ
[105Kcal] × body weight [kg]0.75/day [21]) using the esti-
mated target weight. The exact level of restriction for
each dog was then individualised based upon gender,
and was typically between 50–60 % of MER at target
weight [11]. Owners also implemented lifestyle and
activity alterations to assist in weight loss. Dogs were
reweighed every 7–21 days and changes made to the
food allocation if necessary.
Throughout weight loss, patients were weighed on
electronic scales (Soehnle Professional, Backnang,
Germany), which were regularly calibrated using test
weights (Blake and Boughton Ltd, Thetford, UK). At
the end of the weight management period, a detailed
re-evaluation was conducted which included measure-
ment of body weight, blood sampling, urinalysis, blood
pressure measurement, and assessment of body com-
position assessed by fan-beam DEXA (Lunar Prodigy
Advance; GE Lunar, Madison, Wisc, USA) [11, 22].
Estimation of nutrient intake
Average, maximum and minimum intakes of each nu-
trient were calculated for the period of weight man-
agement for each dog. Maximum and minimum daily
intakes were defined as the greatest and least daily in-
take that the dog received during the period of con-
trolled weight loss, whilst the average daily intake was
defined as the mean daily intake for the whole weight
loss period. The number (and percentage) of dogs with
daily intake of essential nutrients less than NRC 2006 rec-
ommendations (per kg of ideal body weight0.75) was then
determined, whereby minimum requirement (MR) was
defined as ‘the minimal concentration of a maximally bio-
available nutrient that will support a defined physio-
logical state’, recommended allowance (RA) was
defined as ‘the concentration of nutrient demonstrated
to support a defined physiological state’, and adequate
intake (AI) was defined as ‘the concentration of nutri-
ent demonstrated to support a defined physiological
state when no MR has been demonstrated’ [15].
Data handling and analysis
All study data are available in the supplemental mater-
ial (see Additional file 2). Absolute data are expressed
as median (range). Datasets were complete for most
variables except for four serum biochemistry variables
where small numbers of results were missing: alkaline
phosphatase (pre-weight-loss: 1 result), glucose (pre-
weight-loss: 2 results; post-weight-loss: 3 results),
phosphate (pre-weight-loss: 1 result), potassium (post-
weight-loss: 2 results), and free thyroxine (post-weight-
loss: 2 results). There were no other missing data for
any variable. Given the small numbers of missing data
points, no correction was made in statistical analysis.
For each dog, the daily intake of all essential nutrients
was calculated, based upon their food allocation and
the average nutrient content of the diet (Table 1). Stat-
istical analyses were performed with computer software
(Stats Direct version 2.6.8, Stats Direct Ltd), with the
level of significance set at P < 0.05 for two-sided ana-
lyses. Given that there were no known previous studies
examining adequacy of essential nutrient intake in
obese dogs undergoing weight loss, it was not possible
to perform a meaningful power calculation. Instead, as
many dogs as possible were enrolled that the met the
eligibility criteria. The Shapiro-Wilk test was used to as-
sess all data sets and, because many were not normally
distributed, non-parametric tests were used in preliminary
analyses. These included the signed ranks test, the Mann–
Whitney U test, Kendall’s rank correlation, and Fisher’s
exact test. In addition, simple and multiple regression
analysis was used to determine associations between
variables, and the Shapiro-Wilk test was also used to
confirm that the distribution of the residuals of each
regression model followed a normal distribution. Vari-
ables assessed included baseline variables (e.g. age,
sex, neuter status, breed, and body fat percentage)
and weight loss parameters (e.g. percentage weight
loss, rate of weight loss, change in lean tissue, and
energy intake during weight loss).
For linear regression of changes in lean tissue mass
and circulating albumin concentration, factors tested
included signalment (e.g. age at enrolment, sex, breed
group [retriever vs. not retriever]), baseline parameters
(e.g. percentage body fat pre-weight-loss, starting body
weight, lean tissue mass pre-weight loss [in kg]),
weight loss outcomes (duration of weight loss, percent-
age weight loss, energy intake during weight loss, and
percentage change in body fat mass), and nutrient sta-
tus. For the latter, dogs were classified according to a
binary variable, whereby 0 = meets its NRC 2006 RA,
and 1 = does not meet its NRC 2006 RA. Both the
average daily intake and the minimum daily intake dur-
ing the weight loss period were assessed separately.
Percentage change in fat mass was calculated using the
following formula: (fat mass [kg]POST – fat mass
[kg]PRE) ÷ fat mass [kg]PRE × 100); similarly, percentage
change in lean mass was calculated as: (lean mass
[kg]POST – lean mass [kg]PRE) ÷ lean mass [kg]PRE ×
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100). Initially, simple linear regression was used. A
multiple linear regression model was then con-
structed, which initially included any variables identi-
fied as P < 0.2 on univariable analysis. Collinearity
amongst variables was assessed such that unnecessary
collinear predictors were removed. The model was
then refined by backwards-stepwise elimination of the
least significant variable at each round, with variables
being retained in the final model if they were signifi-
cant (P < 0.05).
Results
Dogs and outcome of weight loss
During the study timeframe, a total of 149 dogs were
enrolled in a weight loss regime and potentially eligible
for study recruitment. Of these, 82 dogs reached their
target weight, and the period of weight management
was at least 182 days in 52 dogs. Of these 52 dogs, 40
had been fed a single type of dry food (Table 1). After
excluding dogs that were not euthyroid, were not on
concurrent medication, or had incomplete clinical data
(laboratory and DEXA scan results), a final group of 27
dogs were eligible for inclusion. These dogs represented
a range of ages, breeds and sexes (Table 2), and the me-
dian period of weight loss was 293 days (range 182–674
days). All dogs remained well throughout, and no diet-
related abnormalities were noted on physical examin-
ation, before, during, and after the period of weight
loss. Median weight loss was 28.3 % (16.0-40.1 %) start-
ing body weight (SBW), with a median rate of 0.6 %
(0.2-1.4 %) SBW/week, and the bulk of the tissue lost
was fat with a lesser amount of lean tissue (Table 2).
The mean daily energy intake during weight loss was
61 Kcal/kg0.75 (44–74 Kcal/kg0.75), maximum daily en-
ergy intake was 63 Kcal/kg0.75 (45–77 Kcal/kg0.75), and
minimum daily energy intake was 60 Kcal/kg0.75 (43–71
Kcal/kg0.75).
Laboratory assessments
All dogs remained euthyroid throughout the trial, and
serum free thyroxine concentration did not change sig-
nificantly from beginning to end (Table 3; P = 0.562).
Routine haematological and serum biochemical ana-
lyses were also performed (Table 3); occasional results
were marginally outside the reference range, as re-
ported in similar studies [4, 5, 18]. Also as previously
reported [4, 5, 18], white blood cell counts, and con-
centrations of albumin, calcium, cholesterol, creatinine,
and globulins all decreased during weight loss, whilst
urea concentration increased (Table 3). However, for
the most part, changes were minor, and the majority
remained within the reference range.
Comparison with National Research Council 2006
recommendations
Average, maximum and minimum daily intakes of essen-
tial nutrients for each dog (expressed per kg BW0.75)
were calculated for the whole weight management
period (Table 4), and compared with NRC 2006 recom-
mendations (Table 5). The intake of the majority of es-
sential nutrients was greater than all NRC 2006 cut-offs,
with the exception of selenium, choline, methionine and
cysteine, tryptophan, total fat, magnesium, and potas-
sium. For selenium, the minimum daily intake was less
than both RA and AI in all dogs. For choline, the mini-
mum daily intake was less than RA in 24/27 dogs
(89 %), but less than AI in only 2 dogs (7 %). For me-
thionine and cysteine, the minimum daily intake was less
than RA in 12 dogs (44 %), but minimum intake was
never less than MR in only 2 dogs (7 %). Finally, mini-
mum daily intake was less than RA for tryptophan (2
dogs, 7 %), magnesium (27 dogs, 100 %), and potassium
(2 dogs, 7 %), but was never less than MR in any dog.
Association between nutrients with borderline intakes
and changes in either lean tissue and serum
albumin concentration
Given that, in some dogs, intake of certain nutrients was
borderline, the possibility that these might be associated
Table 2 Summary of weight loss in the study dogs
Criterion Result
Age (months) 70 (24 to 228)
Sex 1 M, 16 NM, 1 F, 9 NF
Breed Alaskan Malamute, Border
Collie, CKCS (4), Cocker Spaniel,
Corgi, Dachshund, Doberman (2),
Golden Retriever, Irish Setter,
Labrador (6), Mixed Breed (3),
Pug (2), Samoyed, Yorkshire Terrier (2)
Body weight PRE (kg) 32.9 (6.7 to 66.8)
Body weight POST (kg) 23.2 (5.0 to 48.0)
Body fat mass PRE (%) 47 (31 to 55)
Body fat mass POST (%) 30 (19 to 45)
Duration (days) 293 (182 to 674)
Rate of weight loss (%/week)a 0.6 (0.2 to 1.4)
Body weight change (%)b −28.3 (−16.0 to −40.1)
Change in fat mass (%)b −52 (−67 to −16)
Change in lean mass (%)b −10 (−21 to +5)
EI during weight lossc 256 (184 to 308) [61 (44 to 74)]
All data are expressed as median (range). M: male; NM: neutered male;
F: female; NF: neutered female; CKCS: Cavalier King Charles Spaniel
aRate of weight loss expressed as percentage of starting body weight lost
per week
bRefers to the percentage change in starting mass calculated as follows: ([start
mass – end mass] ÷ start mass) ×100%
cEI: energy intake expressed as metabolisable energy (in kJ [Kcal]) per kg of
metabolic body weight (BW0.75) per day
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with changes in lean tissue mass and circulating albumin
concentration was explored using linear regression. Sel-
enium was not assessed separately because all dogs had
intakes less than RA and, therefore, this factor did not
discriminate dogs. On simple linear regression analysis
(Table 6), one factor (percentage weight loss) was signifi-
cantly associated with change in lean tissue during
weight loss (R = −0.55, R2 = 0.30, P = 0.003), whilst a
number of other factors were also eligible for inclusion
in the preliminary multiple linear regression model (P <
0.2) including: age (R = −0.27, R2 = 0.07, P = 0.170), rate of
weight loss (R = −0.33, R2 = 0.11, P = 0.092), energy intake
(R = 0.28, R2 = 0.08, P = 0.152), average daily intake of me-
thionine and cysteine (R = −0.32, R2 = 0.10, P = 0.107), and
minimum daily intake of choline mean (R = −0.31, R2 =
0.10, P = 0.111). After refinement of the initial model by
backwards stepwise elimination, the best-fit model was
one that included a single variable, percentage weight loss
(more lean tissue loss when greater percentage weight
loss; R = −0.55, R2 = 0.31, P = 0.003; Table 6). Thus, essen-
tial nutrient intake was not associated with changes in
lean tissue during weight loss.
Simple linear regression analysis revealed that only the
duration of weight loss was significantly associated with
changes in serum albumin concentration (R = −0.39, R2 =
0.15, P = 0.046). Two other factors also qualified for inclu-
sion in the preliminary multiple regression model: body
fat prior to weight loss (R = −0.28, R2 = 0.08, P = 0.150),
and the minimum daily intake of choline during weight
loss (R = 0.26, R2 = 0.07, P = 0.184). Once again, after
refinement by backwards stepwise elimination, the
best-fit model was one that included the single variable,
duration of weight loss (the longer the weight loss
period, the greater the decrease in albumin; R = −0.39,
R2 = 0.15, P = 0.046; Table 7). Thus, essential nutrient
intake was not associated with changes in albumin con-
centration during weight loss.
Discussion
In the current study, we have assessed the intake of es-
sential nutrients for obese dogs during a period of con-
trolled weight loss using a purpose-formulated diet. The
intake of most essential nutrients exceeded NRC 2006
RA cut-offs. Although intake was less than RA or MR
for some nutrients, all dogs remained healthy, showing
no clinical signs of nutrient deficiency. It is important to
note that RAs include a safety margin to take into ac-
count predicted nutrient bioavailability, and the actual
bioavailability of individual nutrients might be higher
than assumed in NRC 2006. The significance of dogs
having intakes less than MR for some nutrients during
weight loss is not known. Firstly, it is possible that re-
quirements for essential nutrients might actually change
when dogs are subjected to energy restriction, although
Table 3 Haematological and clinical biochemical results before and after weight loss
Parameter Before weight loss After weight loss Reference range P value
Red blood cells ×1012/L 6.9 (5.3-8.1), 0, 2 6.9 (5.3-8.0), 0, 1 5.5-8.2 0.652
Haemoglobin g/L 16.0 (12.4-18.8), 0, 2 16.0 (11.3-17.9), 0, 3 12.6-19.4 0.690
Haematocrit L/L 0.48 (0.36-0.55), 0, 0 0.47 (0.35-0.54), 0, 0 0.35-0.55 0.880
Platelets ×109/L 276 (13–385), 0, 2 266 (140–444), 0, 0 80-560 0.473
White blood cells ×109/L 10.4 (5.1-18.7), 2, 1 8.2 (4.6-14.0), 0, 5 6.7-18.3 <0.001
Sodium mmol/L 147 (142–153), 0, 0 146 (140–151), 0, 0 140-153 0.155
Potassium mmol/L 4.6 (3.8-6.0), 1, 0 4.2 (3.7-6.0), 1, 1 3.8-5.3 0.199
Calcium mmol/L 2.8 (2.3-3.1), 3, 0 2.6 (1.8-2.9), 0, 2 2.20-2.90 <0.001
Phosphate mmol/L 1.0 (0.5-2.2), 1, 3 1.0 (0.5-1.5), 0, 5 0.8-2.0 0.058
Alanine aminotransferase U/L 44 (18–293), 13, 0 49 (18–238), 13, 0 7-50 0.893
Alkaline phosphatase U/L 74 (23–392), 11, 0 54 (26–295), 8, 0 0-100 0.065
Albumin g/L 32 (28–36), 1, 0 29 (25–36), 2, 0 25-35 <0.001
Cholesterol mmol/L 6.1 (4.1-7.9), 5, 0 5.4 (3.0-7.3), 1, 2 3.5-7.0 0.040
Creatinine μmol/L 84 (44–123), 2, 0 72 (46–114), 1, 0 20-110 0.033
Globulins g/L 31 (22–44), 2, 0 27 (23–42), 1, 0 22-40 0.012
Glucose mmol/L 5.1 (3.3-5.9), 5, 1 5.2 (3.0-7.4), 5, 1 3.5-5.5 0.210
Urea mmol/L 4.6 (1.8-7.6), 4, 5 5.2 (2.4-8.9), 1, 1 3.5-7.0 0.047
Free thyroxine pmol/L 21.0 (7.0-42.9), 2, 0 20.0 (8.4-34.0), 0, 0 6.6-40.0 0.562
Data are expressed as median (range), number of results above reference range, and number below reference range
P values quoted for Wilcoxon signed ranks test comparing pre- and post-weight-loss measurements. In the dogs, before and after weight loss, with low platelet
counts, platelet clumps were identified on a blood smear suggesting that actual numbers were normal
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the exact effect may well differ amongst nutrients. For
example, requirements of many amino acids and B vita-
mins are directly related to energy metabolism [15, 23].
Given that MER declines during weight loss [13], the re-
quirement of some essential nutrients might also
decline. In contrast, requirements for other essential
nutrients (i.e. minerals) are more directly related to
bodyweight, or another exponent, rather than to energy
metabolism [15]. For these essential nutrients, require-
ments might not change during weight loss despite the
Table 4 Daily intake of essential nutrients in 27 obese dogs during weight loss
Nutrient Daily intake
Maximuma Minimumb Averagec
Crude protein (g) 6.55 (4.70-8.04) 6.23 (4.46-7.38) 6.35 (4.58-7.64)
Arginine (g) 0.342 (0.245-0.419) 0.324 (0.232-0385) 0.331 (0.239-0.398)
Histidine (g) 0.129 (0.092-0.158) 0.122 (0.087-0.145) 0.125 (0.090-0.150)
Isoleucine (g) 0.237 (0.170-0.291) 0.225 (0.161-0.267) 0.230 (0.166-0.276)
Methionine & cysteine (g) 0.22 (0.16-0.28) 0.21 (0.15-0.25) 0.22 (0.16-0.26)
Leucine (g) 0.49 (0.35-0.60) 0.46 (0.33-0.55) 0.47 (0.34-0.57)
Lysine (g) 0.259 (0.186-0.318) 0.246 (0.176-0.292) 0.251 (0.181-0.302)
Phenylalanine & tyrosine (g) 0.61 (0.44-0.74) 0.58 (0.41-0.68) 0.59 (0.42-0.71)
Threonine (g) 0.21 (0.15-0.26) 0.20 (0.14-0.23) 0.20 (0.15-0.24)
Tryptophan (g) 0.059 (0.042-0.072) 0.056 (0.040-0.066) 0.057 (0.041-0.068)
Valine (g) 0.27 (0.20-0.34) 0.26 (0.19-0.31) 0.27 (0.19-0.32)
Linoleic acid (g) 0.46 (0.33-0.56) 0.43 (0.31-0.51) 0.44 (0.32-0.53)
Calcium (g) 0.195 (0.140-0.240) 0.186 (0.133-0.220) 0.189 (0.136-0.228)
Phosphorus (g) 0.15 (0.11-0.19) 0.14 (0.10-0.17) 0.15 (0.11-0.18)
Magnesium (mg) 10.7 (7.7-13.1) 10.2 (7.3-12.1) 10.4 (7.5-12.5)
Sodium (mg) 63.0 (45.2-77.3) 59.9 (42.8-71.0) 61.0 (44.0-73.5)
Potassium (g) 0.18 (0.13-0.22) 0.17 (0.12-0.20) 0.17 (0.12-0.21)
Chloride (mg) 189 (136–232) 180 (129–213) 183 (132–221)
Iron (mg) 3.6 (2.6-4.4) 3.4 (2.4-4.0) 3.5 (2.5-4.2)
Copper (mg) 0.4 (0.3-0.5) 0.4 (0.3-0.5) 0.4 (0.3-0.5)
Zinc (mg) 4.3 (3.1-5.3) 4.1 (3.0-4.9) 4.2 (3.0-5.1)
Manganese (mg) 1.5 (1.1-1.9) 1.4 (1.0-1.7) 1.5 (1.1-1.8)
Selenium (μg) 5.1 (3.7-6.1) 5.2 (3.8-6.4) 5.0 (3.6-5.9)
Iodine (mg) 63.0 (45.2-77.3) 59.9 (42.8-71.0) 61.0 (44.0-73.5)
Vitamin A (IU) 440 (316–541) 418 (299–496) 427 (308–514)
Vitamin D3 (IU) 15.25 (10.94-18.71) 14.49 (10.37-17.18) 14.77 (10.65-17.79)
Vitamin E (IU) 17.4 (12.5-21.3) 16.5 (11.8-19.6) 16.8 (12.2-20.3)
Thiamine (mg) 0.567 (0.407-0.696) 0.539 (0.386-0.639) 0.549 (0.396-0.662)
Riboflavin (mg) 1.134 (0.814-1.392) 1.078 (0.771-1.278) 1.099 (0.792-1.323)
Pyridoxine (mg) 0.504 (0.362-0.619) 0.479 (0.343-0.568) 0.488 (0.352-0.588)
Niacin (mg) 3.53 (2.53-4.33) 3.35 (2.40-3.97) 3.42 (2.47-4.12)
Pantothenic acid (mg) 1.01 (0.72-1.24) 0.96 (0.69-1.14) 0.98 (0.70-1.18)
Cobalamin (μg) 3.47 (2.49-4.25) 3.29 (2.36-3.90) 3.36 (2.42-4.04)
Folic acid (μg) 94.5 (67.8-116.0) 89.8 (64.3-106.5) 91.6 (66.0-110.3)
Choline (mg) 54.2 (38.9-66.5) 51.5 (36.8-61.0) 52.5 (37.9-63.2)
The daily intake of all essential nutrients was calculated from their food allocation and the average nutrient content of the diet (Table 1), and expressed per kg
BW0.75. Results are quoted as median (range)
aMaximum daily intake defined as the greatest daily intake that the dog received during the period of controlled weight loss
bMinimum daily intakes defined as the least daily intake that the dog received during the period of controlled weight loss
cMean daily intake was defined as the mean daily intake for the whole period
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decrease in MER. A second issue is the fact that for loss
of lean tissue mass to be minimised during weight loss,
intake of dietary protein must be adequate [14]. How-
ever, it is not known which essential amino acids are
most limiting in a purpose-formulated weight manage-
ment diet. Therefore, additional studies are now re-
quired to assess adequate intake of essential nutrients
during weight loss.
Table 5 Obese dogs not meeting NRC requirements during weight loss
Nutrient Recommended allowancea Adequate intakeb Minimum requirementc
NRCd No. lesse %f NRC No. lesse %f NRC No. lesse %f
Crude protein (g) 3.28 0, 0, 0 0, 0, 0 — — — 2.62 0, 0, 0 0, 0, 0
Arginine (g) 0.110 0, 0, 0 0, 0, 0 — — — 0.092 0, 0, 0 0, 0, 0
Histidine (g) 0.062 0, 0, 0 0, 0, 0 — — — 0.048 0, 0, 0 0, 0, 0
Isoleucine (g) 0.120 0, 0, 0 0, 0, 0 — — — 0.098 0, 0, 0 0, 0, 0
Methionine & cysteine (g) 0.21 7, 12, 9 26, 44, 33 — — — 0.17 1, 2, 1 4, 7, 4
Leucine (g) 0.22 0, 0, 0 0, 0, 0 — — — 0.18 0, 0, 0 0, 0, 0
Lysine (g) 0.110 0, 0, 0 0, 0, 0 — — — 0.092 0, 0, 0 0, 0, 0
Phenylalanine & tyrosine (g) 0.24 0, 0, 0 0, 0, 0 — — — 0.19 0, 0, 0 0, 0, 0
Threonine (g) 0.14 0, 0, 0 0, 0, 0 — — — 0.11 0, 0, 0 0, 0, 0
Tryptophan (g) 0.046 1, 2, 1 4, 7, 4 — — — 0.036 0, 0, 0 0, 0, 0
Valine (g) 0.16 0, 0, 0 0, 0, 0 — — — 0.13 0, 0, 0 0, 0, 0
Linoleic acid (g) 0.36 0, 0, 0 0, 0, 0 0.30 0, 0, 0 0, 0, 0 — — —
Calcium (g) 0.130 0, 0, 0 0, 0, 0 — — — 0.059 0, 0, 0 0, 0, 0
Phosphorus (g) 0.10 0, 0, 0 0, 0, 0 0.10 0, 0, 0 0, 0, 0 — — —
Magnesium (mg) 19.70 27, 27, 27 100,100,100 — — — 5.91 0, 0, 0 0, 0, 0
Sodium (mg) 26.2 0, 0, 0 0, 0, 0 — — — 9.85 0, 0, 0 0, 0, 0
Potassium (g) 0.14 1, 2, 1 4, 7, 4 0.14 1, 2, 1 4, 7, 4 — — —
Chloride (mg) 40 0, 0, 0 0, 0, 0 40 0, 0, 0 0, 0, 0 — — —
Iron (mg) 1.0 0, 0, 0 0, 0, 0 1.0 0, 0, 0 0, 0, 0 — — —
Copper (mg) 0.2 0, 0, 0 0, 0, 0 0.2 0, 0, 0 0, 0, 0 — — —
Zinc (mg) 2.0 0, 0, 0 0, 0, 0 2.0 0, 0, 0 0, 0, 0 — — —
Manganese (mg) 0.16 0, 0, 0 0, 0, 0 0.16 0, 0, 0 0, 0, 0 — — —
Selenium (μg) 11.8 27, 27, 27 100,100,100 11.8 27, 27, 27 100,100,100 — — —
Iodine (mg) 29.6 0, 0, 0 0, 0, 0 — — — 23.6 0, 0, 0 0, 0, 0
Vitamin A (IU) 50 0, 0, 0 0, 0, 0 40 0, 0, 0 0, 0, 0 — — —
Vitamin D3 (IU) 0.45 0, 0, 0 0, 0, 0 0.36 0, 0, 0 0, 0, 0 — — —
Vitamin E (IU) 1.0 0, 0, 0 0, 0, 0 0.8 0, 0, 0 0, 0, 0 — — —
Thiamine (mg) 0.074 0, 0, 0 0, 0, 0 0.059 0, 0, 0 0, 0, 0 — — —
Riboflavin (mg) 0.171 0, 0, 0 0, 0, 0 — — — 0.138 0, 0, 0 0, 0, 0
Pyridoxine (mg) 0.049 0, 0, 0 0, 0, 0 — — — 0.040 0, 0, 0 0, 0, 0
Niacin (mg) 0.49 0, 0, 0 0, 0, 0 0.39 0, 0, 0 0, 0, 0 — — —
Pantothenic acid (mg) 0.49 0, 0, 0 0, 0, 0 0.40 0, 0, 0 0, 0, 0 — — —
Cobalamin (μg) 1.15 0, 0, 0 0, 0, 0 0.92 0, 0, 0 0, 0, 0 — — —
Folic acid (μg) 8.9 0, 0, 0 0, 0, 0 7.1 0, 0, 0 0, 0, 0 — — —
Choline (mg) 56.0 17, 24, 20 63, 89, 74 45.0 1, 2, 1 4, 7, 4 — — —
aRecommended allowance: the concentration of nutrient demonstrated to support a defined physiological state [15]
bAdequate intake: the concentration of nutrient demonstrated to support a defined physiological state when no minimal requirement has been demonstrated [15]
cMinimum requirement: the minimal concentration of a maximally bioavailable nutrient that will support a defined physiological state [15]
dAll requirements are expressed as the unit stated per kg BW0.75
eThe number of dogs with nutrient intakes less than NRC cut-off based upon maximum, minimum, and mean daily intakes, respectively
fThe percentage of dogs with nutrient intakes less than NRC cut-off based upon maximum, minimum, and mean daily intakes, respectively. Please see the footnote
of Table 4 for definitions of maximum, minimum and mean intakes
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The majority of essential nutrients were fed at intakes
(per kg BW0.75/day) above the guidelines recommended
by NRC, throughout the weight loss period. However,
there were some important exceptions to this, most not-
ably selenium, choline, methionine and cysteine. At first
glance, results were most concerning for selenium, since
daily intakes for this mineral were less than AI in all
cases. Selenium is involved in antioxidant pathways as
well as both thyroid and immune system function, with
deficiency reportedly causing anorexia, depression, dys-
pnoea, and coma [24]. None of these signs were evident
in any of the dogs of the current study. Excessive dietary
selenium intake can also have adverse effects in dogs
[24]; further, both AAFCO and FEDIAF have set legal
limits for selenium supplementation. Thus, it can be im-
mensely challenging to formulate a diet appropriately for
selenium content. A second challenge with selenium is
the fact that optimal intake is not as easily determined
as for other nutrients. Most notably, NRC does not re-
port MR for selenium in dogs and, to the authors’ know-
ledge, no studies have examined this, partly because it
can be difficult to measure selenium status accurately in
animals. Nonetheless, a recent in vivo study in obese
dogs, that used the same diet as for the current work,
did not reveal any decrease in selenium status during
weight loss. In fact, urinary selenium excretion was
greater after weight loss, compared with before, perhaps
suggesting that requirements for this essential nutrient
might actually decline during weight loss [18].
Table 6 Simple and multiple linear regression analysis to
determine factors associated with change in lean mass
Variable R R2 Probability
Simple regression
Agea −0.27 0.07 0.170
Sex 0.09 0.01 0.658
Neuter status −0.14 0.02 0.471
Duration of weight loss 0.057 0.00 0.781
Percentage weight loss −0.55 0.30 0.003
Mean EI during weight lossb 0.28 0.08 0.152
Mean rate of weight lossc −0.33 0.11 0.092
Starting percentage body fat −0.28 0.08 0.152
Change in fat massd 0.11 0.01 0.605
Mean daily intake < RDAe
Methionine & Cysteine −0.32 0.10 0.107
Tryptophan −0.21 0.05 0.282
Choline −0.13 0.02 0.514
Minimum daily intake < RDAf
Methionine & Cysteine −0.21 0.05 0.282
Tryptophan 0.05 0.00 0.790
Choline −0.31 0.10 0.111
Final multiple regression model
Percentage weight loss −0.55 0.30 0.003
All data are expressed as median (range). EI: energy intake; RDA: recommended
daily allowance
aAge at the start of the weight loss programme
bMean energy intake expressed as metabolisable energy (in kJ [Kcal]) per kg of
metabolic body weight (BW0.75) per day
cMean rate of weight loss expressed as percentage of starting body weight
per week
dPercentage change in fat mass between the start and end of the weight
loss period
eDummy variable created whereby 1 = the mean daily intake of each nutrient
less than the NRC 2006 RA, and 0 when it was greater [15]
fDummy variable created whereby 1 was assigned when the minimum daily
intake of the nutrient less than the NRC 2006 RA, and 0 was assigned when it
was greater [15]
Table 7 Simple and multiple linear regression analysis to
determine factors associated with change in serum
albumin concentration
Variable R R2 Probability
Simple regression
Agea 0.22 0.05 0.274
Sex 0.18 0.03 0.357
Neuter status 0.01 0.00 0.956
Duration of weight loss −0.39 0.15 0.046
Percentage weight loss 0.01 0.00 0.941
Mean EI during weight lossb 0.04 0.00 0.856
Mean rate of weight lossc 0.19 0.04 0.344
Starting percentage body fat −0.28 0.08 0.150
Change in fat massd −0.02 0.00 0.921
Change in lean massd −0.07 0.00 0.718
Mean daily intake < RDAe
Methionine & Cysteine −0.12 0.01 0.566
Tryptophan −0.03 0.00 0.895
Choline −0.07 0.00 0.714
Minimum daily intake < RDAf
Methionine & Cysteine −0.14 0.02 0.482
Tryptophan −0.03 0.00 0.894
Choline 0.26 0.07 0.184
Final multiple regression model
Duration of weight loss −0.39 0.15 0.046
All data are expressed as median (range). EI: energy intake; RDA: recommended
daily allowance
aAge at the start of the weight loss programme
bMean energy intake expressed as metabolisable energy (in kJ [Kcal]) per kg of
metabolic body weight (BW0.75) per day
cMean rate of weight loss expressed as percentage of starting body weight
per week
dPercentage change in fat or lean mass between the start and end of the
weight loss period; positive and negative values represent gains and losses in
lean mass, respectively
eDummy variable created whereby 1 = the mean daily intake of each nutrient
less than the NRC 2006 RA, and 0 when it was greater [15]
fDummy variable created whereby 1 was assigned when the minimum daily
intake of the nutrient less than the NRC 2006 RA, and 0 was assigned when it
was greater [15]
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Therefore, although less than NRC AI, the intake of sel-
enium in all dogs was probably sufficient.
Choline is a vitamin-like substance that is reportedly
involved in neurotransmission, hepatic lipid metabol-
ism, coagulation, as well as acting as a methyl donor
[15]. In dogs, deficiency of choline causes hypocholes-
terolaemia, vomiting, fatty liver disease, and death [25].
A previous theoretical study suggested that intake of
choline might be at risk of deficiency if marked caloric
restriction was required during weight loss [19]. In the
current study, the daily choline intake of most dogs
(24/27, 89 %) was less than the NRC 2006 RA for some
of their period of weight loss, although intake was less
than the suggested AI in only two dogs (7 %). However,
requirements for choline have not been well established
in dogs, and the current AI for choline is based on data
from studies conducted over 50 years ago [16]. There-
fore, it is unclear as to whether daily choline intake
during the current study was actually deficient. That
said, a recent study, that used the same diet as for the
current work, demonstrated a 16 % decrease in plasma
choline concentrations during weight loss in obese dogs
[18]. Given that choline is a relatively easy nutrient to
supplement and there are minimal toxicity concerns,
increasing the choline content of canine weight man-
agement diets would seem be sensible until more data
on choline requirements are available.
Similar to the issues for choline, the intake of methio-
nine and cysteine were less than RA in 12 (44 %) and
less than MR in 2 (7 %) of the dogs undergoing weight
loss in the current study. As with choline, these amino
acids were also identified as ‘at risk’ in a recent theoret-
ical study [19]. Methionine is a sulphur-containing
amino acid that is not only required for protein synthe-
sis, but also forms part of the coenzyme s-adenosyl me-
thionine [26]. As a result, its deficiency can result in
various metabolic aberrations [26]. Cysteine is a critical
amino acid for maintaining the secondary structure of
compounds such as glutathione and those required for
hair synthesis. Cysteine is synthesised from methionine
and, therefore, both amino acids are typically consid-
ered together when determining requirements. When
methionine is deficient in the diet, there is an immedi-
ate decrease in food intake, and severe weight loss [27].
Whilst all dogs lost weight during the study, this was
not likely to be due to methionine or cysteine defi-
ciency because food intake was never affected and
weight loss occurred in a controlled fashion and was
never excessive (i.e. < 3 % per week). Puppies fed a
methionine-deficient diet also develop dermatological
lesions such as erythema, footpad necrosis and hyper-
keratosis [28], while adult dogs fed a diet with border-
line methionine and taurine content, develop gallstones
[29, 30]. None of the dogs in the current study, or
indeed from the larger cohort of dogs seen at our
weight management clinic, developed any dermato-
logical signs at any stage during or after their period of
weight loss. Given that abdominal ultrasonography was
not performed, it is unclear as to whether or not gall-
stones had developed. That said, this possibility is less
likely, given that the diet was also supplemented with
taurine (which can partially substitute for methionine
and cysteine), and none of the dogs were taurine defi-
cient (data not shown). Further, no signs were noted
pertaining to liver disease, and clinicopathological
markers of biliary system disturbance (e.g. bilirubin,
and liver enzyme activity) were unchanged after weight
loss. Finally, given the requirement of both methionine
and cysteine for protein synthesis, the effect of daily in-
take on change in lean tissue mass and also serum albu-
min concentration were assessed, and no associations
were seen with either. Nonetheless, as with choline,
supplementing methionine and cysteine in the current
diet by 15 % would ensure that daily intake is greater
than NRC MR. Such a reformulation would be sensible
until further data are available clarifying the safety of
intakes of the level in the current study.
There were a number of other nutrients where intake
was less than the RA suggested by the NRC [15]. These
included tryptophan, magnesium, and potassium. The
significance of these observations is not known since
intake was always above MR throughout weight loss,
there were no signs of deficiency for any of these nutri-
ents, and no association was seen with changes in lean
tissue or serum albumin.
As with all studies, a number of limitations exist.
Firstly, the data were collected retrospectively, and dogs
included were drawn from a larger population. Given
the eligibility criteria used, and most notably the dur-
ation of the weight loss period, a number of dogs were
excluded since they reached target weight within
6 months. Other dogs were excluded because different
weight loss diets had been used, clinical data were miss-
ing, the dogs either had another disease, or they were
on concurrent drug therapy. It is possible that, by ex-
cluding dogs in this way, the results might have been
unfairly biased. That said, dogs were not excluded for
becoming sick or ill, perhaps the most important out-
come factor of interest for the study. Further, to the au-
thors’ knowledge, no nutrient deficiencies have ever
been recognised in any dog that has attended the
weight management clinic where the study was con-
ducted, and this includes the dogs from the current
study. Nonetheless, it would be worth considering a
prospective study, to confirm the current findings in a
cohort of obese dogs undergoing weight loss.
Given that client-owned dogs were used, a second
limitation was the diversity in the population of dogs
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used, which is arguably more marked than would have
been the case for a study undertaken on dogs from a re-
search colony. Not only was the population more di-
verse, but also the environment in which the dogs were
kept was more variable, not least with regard to control-
ling food intake. To offset this, owners measured food
out precisely using kitchen scales, maintained a diary
record, and dogs were only included dogs if there was
no evidence of poor compliance i.e. recorded feeding of
additional foodstuffs. That said, under-reporting is a
concern with the use of food questionnaires [11, 31]
and, as a result, it is possible that some dogs received
additional food, causing errors in estimation of adequate
intake. Whilst this is a notable limitation, the use of
client-owned dogs means that the results are arguably
more representative for the target population of interest,
than using dogs from a research colony.
A third limitation regarding the population was the
fact that it was very variable in terms of breed, age gen-
der, presence of concurrent diseases, and in outcome.
For this reason we applied very strict eligibility criteria,
for instance measurement of body composition by
DEXA. As a result, the final population was closely
monitored, well phenotyped, and all data were complete.
A fourth limitation was the fact that, since the study
was conducted over a number of years and there was no
actual analysis of the batches of food used. Instead, the
nutrient intake for each dog was based upon the average
nutrient content of the diet, based upon analysis. Thus,
actual nutrient intake might have differed from that re-
ported in the current study. Further, whilst we observed
no obvious clinical signs of malnutrition, based upon
physical examination, the outcomes measured might not
have adequately assessed nutrient status or detected sub-
clinical deficiencies. For instance, plasma nutrient status
was not measured. However, such a study has recently
been performed, in a similar cohort of dogs [18], which
demonstrated no change in the plasma concentrations of
most key nutrients during weight loss.
A final limitation relates to generalisability of the data
to canine weight loss programmes in general. Given the
use of client-owned dogs, results should be broadly
representative of weight loss programmes using this or
similar diets in practice although, since the final popula-
tion was small, subtle individual issues with a particular
breed or dog type might have been missed. Further, the
population came from a referral clinic and so might not
be typical of the usual dogs undergoing weight man-
agement. Moreover, only a single weight loss diet was
used and, thus, findings might not be generalisable to
other weight loss diets, especially those from other
manufacturers. Therefore, it would be worth consider-
ing individual validation of other weight loss strategies
in the future.
Conclusion
In conclusion, the current study reports daily intakes of
essential nutrients in a cohort of obese dogs that suc-
cessfully completed a weight loss regime of at least
6 months’ duration, and showed no signs of nutrient de-
ficiency. For some essential nutrients, such as selenium,
choline, methionine and cysteine, daily intake was bor-
derline in some dogs during weight loss.
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